Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

J. D. Weinberg
J. D. Weinberg
New York +1 212 841 1037 jweinberg@cov.com Download V-card

J. D. Weinberg represents buyers, sellers and financial advisors in connection with domestic and cross-border mergers and acquisitions transactions, including acquisitions of public companies, negotiated sales of private companies, subsidiaries and divisions, private equity transactions, leveraged buy-outs and strategic investments. He has advised numerous boards of directors and has been consistently recognized as a leading M&A lawyer by Chambers USA, Legal 500 US and New York Super Lawyers. He is a member of the Committee on Mergers, Acquisitions and Proxy Contests of the New York City Bar Association.

  • Oregon Steel Mills (NYSE: OSM) in its acquisition by Evraz Group SA.
  • The Goodyear Rubber & Tire Company in the sale of its Engineered Products Division to The Carlyle Group. 
  • Thomson Reuters in the sale of its Healthcare division to Veritas Capital and its acquisitions of Information Holdings Inc. (NYSE: IHI) and Solucient. 
  • Johnson & Johnson in its acquisitions of Torax Medical, Sentio, Megadyne, NeuWave, X01, SterilMed, RespiVert, Acclarent, SurgRx, Olive Medical, Link Spine Group, Egea Biosciences and TransForm Pharmaceuticals, in the sale of its global Splenda® business to Centerbridge Partners and Heartland Food Products Group, its Asia Pacific oral care business to LG Household & Healthcare and its COMPEED® business to HRA Pharma, and in other divestitures to Energizer Holdings, Valneva, Air Liquide, Helsinn and Trimb Healthcare AB.
  • Hewlett Packard Enterprise in its acquisitions of BlueData, Plexxi, and Cloud Cruiser.
  • Pfizer in its acquisitions of CovX, Rinat Neuroscience and Bioren. 
  • UCB in the sale of its specialty generics division to Lannett and, previously, the announced sale to Advent International and Avista Capital Partners, in its acquisitions of Element Genomics, Beryllium, LLC and the rights to Proximagen’s Midazolam, in its investment in Dermira and in connection with its collaboration with Amgen.
  • Memory Pharmaceuticals Corp. (NASDAQ: MEMY) in its sale to Roche Group.
  • NYSE Euronext in its acquisition by IntercontinentalExchange and in its abandoned merger with Deutsche Börse AG (financial advisor).
  • CA in its acquisitions of Platinum Technology (NASDAQ: PLAT) and Sterling Software (NYSE: SSW), two of the largest software deals at the time.
  • BBVA Compass Bank in its acquisition of Simple Finance Technology.
  • MidFirst Bank in its acquisitions of 1st Century Bancshares, Inc. (NASDAQ: FCTY), of Presidential Financial Corporation from Harbert Private Equity and the Belfer family and of Steele Street Bank & Trust.
  • Kate Spade & Company in its sale to Coach (financial advisor).
  • UST in its sale to Altria (financial advisor).
  • International Coal Group in its sale to Arch Coal (financial advisor).
  • UBS in its acquisition of Enron's gas and power trading business, including its Enron Online trading platform.
  • International Steel Group in its sale to Mittal Steel (financial advisor).
  • National Amusements in its acquisition of a controlling interest in Midway Games (NYSE: MWY) from Sumner Redstone.
  • Orix Corporation in its unsolicited offer to acquire Criimi Mae (NYSE: CMM).
  • Freddie Mac in connection with establishment of Federal government conservatorship.
  • Gilead Sciences in its acquisition of CGI Pharmaceuticals. 
  • The special committee of JCrew in its sale to TPG and Leonard Green Partners (financial advisor).
  • Ryerson Inc. in its acquisition by Platinum Equity (financial advisor).
  • Interpublic in its acquisition of Adair-Greene.
  • Sotheby’s in the sale of its real estate brokerage to Realogy, including in the long-term license of the Sotheby’s trademark.
  • Esmark in its proposed acquisition by Essar, and ultimate acquisition by Severstal (financial advisor).
  • Wheeling-Pittsburgh Corporation in its merger with Esmark Inc. (financial advisor) and in its proposed acquisition of the North American assets of Companhia Siderurgica Nacional (financial advisor).
  • IAC/InterActiveCorp in its senior notes offering and in its acquisition of Interval International (NASDAQ: IILG).
  • Private equity investments in Northeast Bancorp (NASDAQ: NBN), Grandpoint Capital in connection with its acquisition of Santa Ana Bank, and Carlile Bancshares in connection with its acquisition of Treaty Oak Bank.
  • Sims Group Limited in its acquisition of Metal Management, Inc. (financial advisor).
  • Bowater in its merger with Abitibi (financial advisor).
  • Duke Energy in its merger with Cinergy (financial advisor).
  • Meda AB in its acquisition of a portfolio of pharmaceutical products from Jazz Pharmaceuticals.
  • Cash America International in connection with its merger of equals with First Cash Financial Services (financial advisor).
  • Pactiv in its sale to Reynolds (financial advisor).
  • Ionics in its sale to General Electric (financial advisor).
  • OMI Corporation in its sale to Teekay Shipping and Torm (financial advisor).
  • Validus Holdings in its unsolicited offer to acquire IPC Holdings following IPC's announcement of a proposed amalgamation with Max Capital Group (financial advisor).

Memberships and Affiliations

  • Committee on Mergers, Acquisitions and Proxy Contests, Association of the Bar of the City of New York, appointed Member (2009-2012; 2013-)
  • Columbia University, Board of Visitors of the Department of History, Member
  • Young New Yorkers, Advisory Board
  • Chambers USA, America's Leading Business Lawyers, Corporate/M&A (New York) (2009-2018)
  • Chambers Global, Corporate/M&A (2014-2015) 
  • Legal 500 US, Mergers & Acquisitions - M&A: Large Deals (2009-2010, 2013-2017)
  • New York Super Lawyers, Mergers & Acquisitions (2006-2008, 2012-2016)
  • Best Lawyers in America, Leveraged Buyouts and Private Equity Law (2016-2018)
  • Who's Who Legal, Life Sciences - Transactional  (2016-2017)